Design and synthesis of a novel, orally active, brain penetrant, tri-substituted thiophene based JNK inhibitor
Journal Article
·
· Bioorg. Med. Chem. Lett.
The SAR of a series of tri-substituted thiophene JNK3 inhibitors is described. By optimizing both the N-aryl acetamide region of the inhibitor and the 4-position of the thiophene we obtained single digit nanomolar compounds, such as 47, which demonstrated an in vivo effect on JNK activity when dosed orally in our kainic acid mouse model as measured by phospho-c-jun reduction.
- Research Organization:
- Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
- Sponsoring Organization:
- USDOE Office of Science (SC)
- OSTI ID:
- 1026549
- Journal Information:
- Bioorg. Med. Chem. Lett., Journal Name: Bioorg. Med. Chem. Lett. Journal Issue: (6) ; 03, 2011 Vol. 21
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK
Synthesis and SAR of piperazine amides as novel c-jun N-terminal kinase (JNK) inhibitors
Substituted N-aryl-6-pyrimidinones: A new class of potent, selective, and orally active p38 MAP kinase inhibitors
Journal Article
·
Mon Feb 27 23:00:00 EST 2012
· Bioorg. Med. Chem. Lett.
·
OSTI ID:1026552
Synthesis and SAR of piperazine amides as novel c-jun N-terminal kinase (JNK) inhibitors
Journal Article
·
Mon Sep 14 00:00:00 EDT 2009
· Bioorg. Med. Chem. Lett.
·
OSTI ID:1005841
Substituted N-aryl-6-pyrimidinones: A new class of potent, selective, and orally active p38 MAP kinase inhibitors
Journal Article
·
Mon Feb 27 23:00:00 EST 2012
· Bioorg. Med. Chem. Lett.
·
OSTI ID:1026534